Detalhe da pesquisa
1.
Low-dose peginterferon alfa-2a is safe and produces a sustained virologic response in patients with chronic hepatitis C and end-stage renal disease.
Clin Gastroenterol Hepatol
; 9(3): 242-8, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21056689